Moderna and Pfizer Begin Late-Stage Coronavirus Vaccine Trials - The New York Times
Moderna - Moderna Announces an Array of Clinical Advances and Outlines 2018 Priorities; 19 Development Candidates, including 10 Clinical Programs, Highlight Productivity of mRNA Platform
Moderna COVID-19 vaccine clinical trial for people with organ transplant starts at Feinstein Institutes | Northwell Health
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM
Moderna wins bragging rights as it kick-starts first experimental coronavirus clinical trial | Fierce Biotech
Rutgers Selected as Site for COVID-19 Vaccine Clinical Trial | Rutgers University
A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age - Full Text View - ClinicalTrials.gov
Moderna Launches Clinical Trial of Its mRNA HIV Vaccine – NBC4 Washington
Moderna starts clinical trial of booster shot targeting omicron Covid variant
Moderna releases new Covid-19 vaccine data, final trial start data - Boston Business Journal
Moderna takes mRNA HIV candidate into clinical trials
Moderna, Inc. - The ClinicalTrials.gov listing for Moderna's Phase 3 study of mRNA-1273, our #vaccine candidate against COVID-19 is now live. Find more information on the study including site locations here: https://buff.ly/2WiCYby
Moderna starts trial for Omicron-specific booster shot | Reuters
Some Teens Volunteer for Covid Vaccine Trials to Get Their Lives Back - The New York Times
Clinical Trials, Speed And Special Technology: Developing The COVID Vaccines | WBUR News
MedicalCountermeasures.gov
Clinical Trial Results for Moderna/NIH Vaccine Released in Preliminary Report - Americans for Medical Progress
NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins | National Institutes of Health (NIH)
Moderna mRNA HIV vaccine: First patients vaccinated in clinical trial - CNN
Moderna set to start human trials of experimental mRNA HIV vaccine
NIH on Twitter: "A Phase 3 clinical trial of investigational vaccine mRNA-1273 to prevent #COVID19, co-developed by #NIH @NIAIDNews and @Moderna, has begun. The multisite trial will assess preventive power, enrolling 30k+
Trial of Coronavirus Vaccine Made by Moderna Begins in Seattle - The New York Times
NIH clinical trial of investigational vaccine for COVID-19 begins | National Institutes of Health (NIH)
Moderna vaccine shows 94.1% efficacy in a Phase 3 clinical trial | Healthcare Finance News
Moderna trial studies COVID-19 vaccine for children - UCHealth Today
